The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Early diagnosis and treatment of type 1 diabetes mellitus. Issues of clinical feasibility, organization, and accessibility of medical care. Resolution on the results of the Expert Council held on December 17, 2024, Moscow

Journal: Medical Technologies. Assessment and Choice. 2025;47(2): 10‑17

DOI: 10.17116/medtech20254702110

Read: 1027 times

Download PDF (RU)
Contact the author
Table of contents

EARLY DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES MELLITUS. ISSUES OF CLINICAL FEASIBILITY, ORGANIZATION, AND ACCESSIBILITY OF MEDICAL CARE. RESOLUTION ON THE RESULTS OF THE EXPERT COUNCIL HELD ON DECEMBER 17, 2024, MOSCOW
EARLY DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES MELLITUS. ISSUES OF CLINICAL FEASIBILITY, ORGANIZATION, AND ACCESSIBILITY OF MEDICAL CARE. RESOLUTION ON THE RESULTS OF THE EXPERT COUNCIL HELD ON DECEMBER 17, 2024, MOSCOW

To cite this article:

Early diagnosis and treatment of type 1 diabetes mellitus. Issues of clinical feasibility, organization, and accessibility of medical care. Resolution on the results of the Expert Council held on December 17, 2024, Moscow. Medical Technologies. Assessment and Choice. 2025;47(2):10‑17. (In Russ.)
https://doi.org/10.17116/medtech20254702110

 
Подписка 2026 Медицинские технологии. Оценка и выбор (Medical Technologies. Assessment and Choice)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Early diagnosis and treatment of type 1 diabetes mellitus. Issues of clinical feasibility, organization, and accessibility of medical care. Resolution on the results of the Expert Council held on December 17, 2024, Moscow.

Close metadata

References:

  1. Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. The Lancet Diabetes & Endocrinology. 2022.10(10):741-760.  https://doi.org/10.1016/S2213-8587(22)00218-2
  2. Klinicheskie rekomendacii. Sakharnyj diabet 1 tipa u detej. 2022. Accessed November 11, 2024. (In Russ.). https://cr.minzdrav.gov.ru/view-cr/287_2
  3. Ammira Al-Shabeeb Akil, Esraa Yassin E, Al-Maraghi A, Aliyev E, Al-Malki Kh, Fakhro KA. Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era. Journal of Translational Medicine. 2021;19(1):137.  https://doi.org/10.1186/s12967-021-02778-6
  4. Svane J, Lynge TH, Pedersen-Bjergaard U, Jespersen T, Gislason GH, Risgaard B, et al. Cause-specific mortality in children and young adults with diabetes mellitus: A Danish nationwide cohort study. European Journal of Preventive Cardiology. 2021;28(2):159-165.  https://doi.org/10.1177/2047487319836550
  5. Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2021;64(2):275-287.  https://doi.org/10.1007/s00125-020-05319-w
  6. Laptev DN, Bezlepkina OB, Sheshko EL, Aleksandrova GA, Chumakova OV, Krestovskaya NM, et al. Main epidemiological indicators of type 1 diabetes mellitus in children in the Russian Federation for 2014—2023. Problems of Endocrinology. 2024;70(5):76-83. (In Russ.) https://doi.org/10.14341/probl13515
  7. Sims EK, Besser REJ, Dayan C, Rasmussen CG, Greenbaum C, Griffin KJ, et al. Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective. Diabetes. 2022;71(4):610-623.  https://doi.org/10.2337/dbi20-0054
  8. Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309(23):2473-9.  https://doi.org/10.1001/jama.2013.6285
  9. Primavera M, Giannini C, Chiarelli F. Prediction and Prevention of Type 1 Diabetes. Frontiers in Endocrinology. 2020;11:248.  https://doi.org/10.3389/fendo.2020.00248
  10. Haller MJ, Bell KJ, Besser REJ, Casteels K, Couper JJ, Craig ME, et al. ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes. Hormone Research in Pediatrics. 2024;11:1-17.  https://doi.org/10.1159/000543035
  11. Larsson HE, Vehik K, Bell R, Dabelea D, Dolan L, Pihoker C, et al. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care. 2011;34(11):2347-52.  https://doi.org/10.2337/dc11-1026
  12. Mortensen HB, Swift PGF, Holl RW, Hougaard P, Hansen L, Bjoerndalen H, et al. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatric Diabetes. 2010;11(4):218-26.  https://doi.org/10.1111/j.1399-5448.2009.00566.x
  13. Duca LM, Wang B, Rewers M, Rewers A. Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control. Diabetes Care. 2017 Sep;40(9):1249-1255. https://doi.org/10.2337/dc17-0558
  14. Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care. 2004 Jun;27(6):1399-404.  https://doi.org/10.2337/diacare.27.6.1399
  15. Besser REJ, Ng SM, Gregory JW, Dayan CM, Randell T, Barrett T. General population screening for childhood type 1 diabetes: is it time for a UK strategy? Archives Disease Childhood. 2022;107(9):790-795.  https://doi.org/10.1136/archdischild-2021-321864
  16. Nedogoda SV, Galstyan GR, Laptev DN, Salasyuk AS, Barykina IN, Lutova VO, et al. Economic analysis of diabetes type 1 screening in children in the Russian Federation. Medical Technologies. Assessment and Choice. 2024;46(3):104-114. (In Russ.). https://doi.org/10.17116/medtech202446031104
  17. Phillip M, Achenbach P, Addala A, Albanese-O’Neill A, Battelino T, Bell KJ, et al. Consensus Guidance for Monitoring Individuals with Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care. 2024;47(8):1276-1298. https://doi.org/10.2337/dc24-er11a
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.